Does the consent of the patients have a role to play in formulating a treatment policy?
Zambia recently changed its treatment policy for malaria from the failing chloroquine to the more effective artemisinin combination therapy (ACT). A study was conducted to find out if the community accepted the new treatment policy, as a prediction of its success. Following high levels of acceptability, it was not surprising to see high levels of compliance and subsequent reduction in cases of severe malaria and deaths.
Kango
M
M
Ministry of Health-Zambia, PO Box 32144, Lusaka, Zambia. mkango@nmcc.org.zm
Baboo
K S
KS
D000328:Adult; D000962:Antimalarials / Q000627:therapeutic use*; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins / Q000627:therapeutic use*; D003430:Cross-Sectional Studies; D004338:Drug Combinations; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D005449:Fluorenes / Q000627:therapeutic use*; D006291:Health Policy; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D010342:Patient Acceptance of Health Care; D010349:Patient Compliance; D015024:Zambia
D000962:Antimalarials; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins; D004338:Drug Combinations; D004983:Ethanolamines; D005449:Fluorenes